Skip to main content
. Author manuscript; available in PMC: 2013 Jun 1.
Published in final edited form as: Acad Emerg Med. 2012 Jun;19(6):694–702. doi: 10.1111/j.1553-2712.2012.01375.x

Table 3.

Guideline Elements: Outcomes (>80% Panel Consensus)

An ED-based risk stratification tool should:
 11 Identify serious outcomes that are recognized during the ED evaluation
 12 Identify serious outcomes occurring within 7 days after the ED visit
 13 Identify serious outcomes occurring 7–30 days after the ED visit
Clinically important serious outcomes that should be predicted by a risk stratification tool include:
Mortality:
 14 Cardiac death
 15 Syncope-related death
Arrhythmias
 16 Ventricular fibrillation
 17 Ventricular tachycardia > 30 seconds
 18 Symptomatic ventricular tachycardia < 30 seconds
 19 Sick sinus syndrome with alternating sinus bradycardia and tachycardia
 20 Sinus pause > 3 seconds
 21 Mobitz type II atrioventricular heart block
 22 Complete heart block
 23 Pacemaker or implantable cardioverter-defibrillator malfunction with cardiac pauses.
Structural/ Ischemic Heart Disease
 24 Aortic stenosis with valve area ≤ 1 cm2
 25 Hypertrophic cardiomyopathy with outflow tract obstruction
 26 Left atrial myxoma or thrombus with outflow tract obstruction
 27 Myocardial infarction
Other Outcomes
 28 Pulmonary embolus
 29 Aortic dissection
 30 Internal hemorrhage or anemia requiring transfusion
 31 Recurrent syncope or fall resulting in major traumatic injury (trauma that requires admission or procedural/surgical intervention)
 32 Permanent pacemaker or defibrillator placement
 33 Cardiopulmonary resuscitation